Scilex Holding Company Revenue per Employee (SCLX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Scilex Holding Company  (NASDAQ: SCLX)
 

Scilex Holding's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Scilex Holding's Revenue per employee fell on a trailing twelve month basis to $ 929,647, but the productivity of Scilex Holding's employees remained above the company average.
Within the Healthcare sector Employees of 80 other companies have achieved higher revenue per employee. While Scilex Holding's total ranking has deteriorated compared to the previous quarter from 784 to 849. Scilex Holding has 34 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SCLX Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change -22.78 % 72.12 % -67.83 % -26.85 % -39.55 %
Sales per Employee (TTM) $ 929,647 995,941 889,794 1,187,059 1,301,059
SCLX's Total Ranking # 849 # 784 # 2520 # 1717 # 1751
Seq. Revenue Change -11.27 % 79.7 % -54.61 % 6.71 % 97.76 %

SCLX Company Profile >> Back to SCLX Efficiency Comparisons >> Compare SCLX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 14
Healthcare Sector # 81
Overall Market # 849

Revenue per Employee Statistics
High Average Low
$ 2,097,500 $ 1,369,380 $ 889,794
(Sep 30 2023)   (Dec 31 2025)



Financial Statements
Scilex Holding's Revenue MRQ $ 8 Millions Visit SCLX's Income Statement
Scilex Holding's Revenues TTM $ 32 Millions Visit SCLX's aggregate revenue growth
What are SCLX's Sales? Visit SCLX's Sales by Segment




Other Ratios
Scilex Holding's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
SCLX's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for SCLX's Competitors
Revenue per Employee for SCLX's Suppliers
Revenue per Employee for SCLX's Customers

You may also want to know
SCLX's Sales Growth Rates SCLX's Pe Price to earnings ratio SCLX's Receivables Turnover Ratio SCLX's Stock Quote
SCLX's Net Income Growth Rates SCLX's Ps Price to Sales ratio SCLX's Sales per Employee SCLX's Asset Turnover Ratio
SCLX's Net Margin SCLX's Pb Price to Book ratio SCLX's Financial Strength Ratios SCLX's Dividend Payout Ratio
Date modified: 2026-09-12T06:25:36+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Ideaya Biosciences Inc   1,614,668.97 $ 234.127  Million 145 
Eli Lilly And Company  1,593,316.00 $ 79,665.800  Million 50,000 
Jazz Pharmaceuticals Plc  1,592,122.15 $ 4,601.233  Million 2,890 
Rigel Pharmaceuticals Inc  1,590,718.39 $ 276.785  Million 174 
Progyny Inc   1,531,890.19 $ 1,311.298  Million 856 
Krystal Biotech Inc   1,493,166.10 $ 440.484  Million 295 
Acadia Pharmaceuticals Inc   1,426,870.93 $ 1,138.643  Million 798 
Madrigal Pharmaceuticals Inc   1,403,213.11 $ 1,283.940  Million 915 
Indivior Pharmaceuticals Inc   1,333,000.00 $ 1,333.000  Million 1,000 
Arcutis Biotherapeutics Inc   1,310,680.79 $ 463.981  Million 354 
Lantheus Holdings Inc   1,303,724.22 $ 1,555.343  Million 1,193 
Cue Biopharma Inc   1,298,413.79 $ 37.654  Million 29 
Puma Biotechnology Inc   1,291,865.92 $ 231.244  Million 179 
Arvinas Inc   1,287,398.37 $ 316.700  Million 246 
Supernus Pharmaceuticals inc   1,273,677.91 $ 830.438  Million 652 
Travere Therapeutics Inc   1,189,798.79 $ 591.330  Million 497 
Heron Therapeutics Inc   1,183,648.44 $ 151.507  Million 128 
Journey Medical Corp  1,175,534.48 $ 68.181  Million 58 
Theravance Biopharma inc   1,159,011.11 $ 104.311  Million 90 
Corcept Therapeutics Inc  1,138,100.00 $ 830.813  Million 730 
Abbvie Inc   1,129,578.95 $ 64,386.000  Million 57,000 
Akebia Therapeutics Inc   1,129,175.26 $ 219.060  Million 194 
Siga Technologies Inc  1,095,079.92 $ 53.659  Million 49 
Biomarin Pharmaceutical Inc  1,057,626.20 $ 3,406.614  Million 3,221 
Hims and Hers Health Inc   1,055,894.35 $ 2,578.494  Million 2,442 
Assembly Biosciences Inc   1,025,273.97 $ 74.845  Million 73 
Sanara Medtech Inc   1,019,592.91 $ 110.116  Million 108 
Ani Pharmaceuticals Inc  1,008,638.14 $ 978.379  Million 970 
Coya Therapeutics Inc   1,002,393.13 $ 8.019  Million 8 
Meiragtx Holdings Plc  986,354.84 $ 397.501  Million 403 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.